IMMUNOTECH LABORATORIES INC

As of September 30, 2006, IMMUNOTECH LABORATORIES INC carries a market capitalization of 144.75M, placing it among publicly traded companies globally. Its enterprise value stands at 145.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2006, IMMUNOTECH LABORATORIES INC has 263,175.00 shares outstanding.

These figures are as of September 30, 2006.

As of September 30, 2006, IMMUNOTECH LABORATORIES INC maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2006. Return on assets (ROA) is negative at -18,563.89, reflecting losses generated across the asset base.

As of the close on October 19, 2026, IMMUNOTECH LABORATORIES INC's stock has gained approximately 100.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

These figures cover the twelve months ended September 30, 2006. EBITDA reached -2.88M, while operating income came in at -2.88M.

As of September 30, 2006, IMMUNOTECH LABORATORIES INC holds 18,530.00 in cash and equivalents against 483,739.00 in total debt, resulting in a net debt position of 465,209.00. Total book value stands at -2.09M, with working capital of -2.32M providing operational flexibility.

IMMUNOTECH LABORATORIES INC produced -301,205.00 in operating cash flow over the twelve months ended September 30, 2006. After subtracting -122,898.00 in capital expenditures, free cash flow totaled -424,103.00 - equivalent to -1.94 per share.

These figures cover the twelve months ended September 30, 2006. Free cash flow yield is negative at -0.35: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.30, meaning IMMUNOTECH LABORATORIES INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

IMMUNOTECH LABORATORIES INC's most recent stock split took place on February 27, 2009 with a 100:1 split ratio.